Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
10041-cover-opener.jpg

November 21, 2022 Cover

Volume 100, Issue 41

The demand for birth control that targets sperm is high. Can the drugs in development overcome the obstacles that have hampered earlier attempts?

Credit: Will Ludwig/C&EN

Full Article
Volume 100 | Issue 41

All Issues

Quote of the Week

“This idea that men won’t take any risk of side effects for contraception—that’s just not true.”

Stephanie Page, professor, University of Washington School of Medicine

  • What chemicals make airbags inflate, and how have they changed over time?

    The chemical reaction used to deploy airbags has evolved, but one iteration resulted in massive recalls

  • UN suggests path to carbon-neutral chemical industry

    Report points to carbon capture, electrochemistry, and biofuels as key technologies

  • GSK reports positive antibiotic trial results

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT